Citius Pharmaceuticals
CTXR
CTXR
54 hedge funds and large institutions have $11.2M invested in Citius Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
40% less capital invested
Capital invested by funds: $18.9M → $11.2M (-$7.62M)
Holders
54
Holding in Top 10
–
Calls
$774K
Puts
$73K
Top Buyers
| 1 | +$282K | |
| 2 | +$226K | |
| 3 | +$217K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$157K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$40.3K |
Top Sellers
| 1 | -$2.28M | |
| 2 | -$460K | |
| 3 | -$184K | |
| 4 |
SG Americas Securities
New York
|
-$108K |
| 5 |
HGWM
Horst & Graben Wealth Management
Portland,
Oregon
|
-$92K |